Effects of hyperglycemia on the development of new-onset diabetes after liver transplantation

Progress in Transplantation

Volumn 19, Issue 4, 2009, Pages 298-303

  Anderson, April L ^a   Lewis, Daniel A ^a   Steinke, Douglas T ^a   Ranjan, Dinesh ^a   Smith, Kelly M ^a   Clifford, Timothy M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; TACROLIMUS;

ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; RISK; UNITED STATES;

DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; TACROLIMUS; UNITED STATES;

EID: 77449120119     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.1177/152692480901900403     Document Type: Article

References (14)

1. Marin M, Renoult E, Bondor CI, Kessler M. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc. 2005;37(4):1851-1856 (Pubitemid 40790849)
2. Romero R, Melde K, Pillen T, Smallwood GA, Heffron T. Persistent hyperglycemia in pediatric liver transplant recipients. Transplant Proc. 2001;33(7-8):3617-3618 (Pubitemid 34044152)
3. Mora PF. Post-transplantation diabetes mellitus. Am J Med Sci. 2005;329(2):86-94 (Pubitemid 40250599)
4. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis. 2004;43(6):953-965 (Pubitemid 38691490)
5. Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for newonset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007;13(1):136-144 (Pubitemid 46099983)
6. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB. New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation. 2005;80(7):945-952 (Pubitemid 41552891)
7. Dansirikul C, Staatz CE, Duffull SB, Taylor PJ, Lynch SV, Tett SE. Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. J Clin Pharm Thera. 2006;31(1):17-25
8. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91-96 (Pubitemid 36055342)
9. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619-1636
10. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002; 25(3):583-592
11. Khalili M, Lim JW, Bass N, et al. New-onset diabetes mellitus after liver transplantation: the critical role of hepatitis C virus infection. Liver Transpl. 2004;10(3):349-355 (Pubitemid 38380307)
12. Bigam DL, Pennington JJ, Carpentier A, et al. Hepatitis Crelated cirrhosis: a predictor of diabetes after liver transplantation. Hepatology. 2000;32(1):87-90 (Pubitemid 30432370)
13. Thomas MC, Moran J, Mathew TH, Russ GR, Rao MM. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol. 2000;1:1
14. Cosio FG, Pesavento TE, Oseil K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59(2):732-737. (Pubitemid 32157939)